leisure time -WSS

leisure time

author：entertainment 2025-10-01 21:37:36 - browse：65

Venture capital firm RA Capital is starting a new incubator, setting the stage for the firm to create new startups over the next several years that hone in on synthetic biology, a long-gestating field that insiders say is getting renewed interest.

The Boston-based VC’s incubator is called RASyn, and will be led by Robert Nicol, according to people familiar with the firm’s plans. Nicol spent more than 20 years at the Broad Institute, where he co-founded the MIT-Broad Foundry for Synthetic Biology, as well as HiFiBio Therapeutics and Design Pharmaceuticals.

RA Capital confirmed RASyn’s existence. Senior Managing Director Josh Resnick told STAT it’s part of the firm’s work to rethink how it develops platforms — core technologies or scientific approaches that underpin all of the drugs a biotech develops — but declined to comment further.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： NIH documents show early flaws of $1.6 billion long Covid program

focus

WSS

UK homeowners get some respite as inflation falls by more than anticipated to a 15

Ultragenyx gene therapy for rare liver ailment succeeds in late

At ASCO, AstraZeneca reports strong data for breast cancer drug

ASCO: AstraZeneca's Tagrisso greatly slowed some lung cancers

Ford plant in Missouri shuts down over 'possible threat,' sheriff's office says

Study: Hearing aids may slow cognitive decline in those at risk

explore

leisure time

hotspot

Apple is now the first public company to be valued at $3 trillion

A look at other Americans who have crossed into North Korea over the years

State Dept. review finds Biden bears some blame for Afghanistan failures

DeSantis says Trump could've 'come out more forcefully' during Jan. 6

BioMarin wins approval for gene therapy to treat hemophilia A

Ionis drug prevents swelling attacks due to hereditary angioedema

Activists slam private health insurers over coverage restrictions

ER docs worry over extreme heat as a 'mass casualty event'

Sports medicine is finally prioritizing gender equality

Letters to First Opinion on caregivers, digital health, and more

explore

Let's speed up science by embracing open access publishing

BMI, flaws aside, is found to be useful estimate of body fat in youth

Ultragenyx gene therapy for rare liver ailment succeeds in late

ASCO: AstraZeneca says CAR

Idaho college killings: Prosecutors dispute DNA could have been planted at murder scene

Ford plant in Missouri shuts down over 'possible threat,' sheriff's office says

entertainment

hotspot

focus

focus